Your browser doesn't support javascript.
loading
Th1-related disease development during omalizumab treatment: Two cases with severe asthma.
Hayashi, Hiroaki; Fukutomi, Yuma; Mitsui, Chihiro; Watai, Kentaro; Tomita, Yasuhiro; Kamide, Yosuke; Sekiya, Kiyoshi; Tsuburai, Takahiro; Horita, Ayako; Saito, Ikuo; Hasegawa, Yoshinori; Taniguchi, Masami.
Affiliation
  • Hayashi H; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fukutomi Y; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Mitsui C; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Watai K; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Tomita Y; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kamide Y; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Sekiya K; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Tsuburai T; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Horita A; Department of Pathology, Sagamihara National Hospital, Sagamihara, Japan.
  • Saito I; Department of Pathology, Sagamihara National Hospital, Sagamihara, Japan.
  • Hasegawa Y; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Taniguchi M; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan. Electronic address: m-taniguchi@sagamihara-hosp.gr.jp.
Allergol Int ; 67(3): 405-407, 2018 Jul.
Article in En | MEDLINE | ID: mdl-29191372

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Th1 Cells / Anti-Asthmatic Agents / Omalizumab Type of study: Diagnostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Allergol Int Journal subject: ALERGIA E IMUNOLOGIA Year: 2018 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Th1 Cells / Anti-Asthmatic Agents / Omalizumab Type of study: Diagnostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Allergol Int Journal subject: ALERGIA E IMUNOLOGIA Year: 2018 Document type: Article Affiliation country: Japan Country of publication: United kingdom